Drug Information Update- Federal judge enters order of permanent injunction against Paul W. Franck

The Division of Drug Information (DDI)- serving the public by providing information on human drug products and drug product regulation by FDA.

The U.S. Food and Drug Administration announced that U.S. District Judge Carlos E. Mendoza entered an order of permanent injunction against Paul W. Franck of Ocala, Florida. According to the complaint filed with the consent decree, Franck manufactured and distributed drug products that were adulterated and misbranded in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The U.S. Department of Justice brought the action on behalf of the FDA.

The order prohibits Franck from manufacturing, holding and distributing sterile drug products until he complies with the FD&C Act and its regulations, in addition to other requirements.  

For more information, please visit: Paul W. Franck.